Polyprotein

Description:

Description
  • Accession: Q6GYR8
  • Swissprot: Q6GYR8_9HEPC
  • Organism: Hepacivirus C
  • Target class: Polyprotein

Drug Relations:

simeprevir
Oral HCV-PROTEASE INHIBITOR effective against hepatitis C virus (HCV) serine protease NS3/4A. It is used in the treatment of chronic hepatitis C (Antivirals) genotype 1 infection in adults with compensated liver disease, including CIRRHOSIS. Bioactivity details MOA